Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 44 | $4,200,938 |
| Sells | 0 | $0 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 29 Apr 2025 06:14 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 25 Apr 2025 | Purchase | 3,600 | 9.88 | 35,568 | D |
| 22 Apr 2025 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 17 Apr 2025 | Purchase | 5,400 | 8.98 | 48,492 | D |
| 08 Apr 2025 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 07 Apr 2025 | Purchase | 3,600 | 9.1 | 32,760 | D |
| 07 Apr 2025 07:50 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 04 Apr 2025 | Purchase | 5,500 | 8.73 | 48,015 | D |
| 13 Jan 2025 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 10 Jan 2025 | Purchase | 2,500 | 12.51 | 31,275 | D |
| 08 Jan 2025 06:10 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 06 Jan 2025 | Purchase | 1,100 | 13.31 | 14,641 | D |
| 08 Jan 2025 06:10 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 07 Jan 2025 | Purchase | 1,800 | 13.75 | 24,750 | D |
| 07 Jan 2025 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 03 Jan 2025 | Purchase | 3,400 | 12.95 | 44,030 | D |
| 06 Jan 2025 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 02 Jan 2025 | Purchase | 2,000 | 11.97 | 23,940 | D |
| 03 Jan 2025 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 31 Dec 2024 | Purchase | 2,400 | 11.36 | 27,264 | D |
| 02 Jan 2025 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 30 Dec 2024 | Purchase | 3,200 | 11.12 | 35,584 | D |
| 25 Nov 2024 06:03 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 21 Nov 2024 | Purchase | 1,000 | 12.91 | 12,910 | D |
| 30 Sep 2024 06:04 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 26 Sep 2024 | Purchase | 1,500 | 14.63 | 21,945 | D |
| 16 Sep 2024 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 12 Aug 2024 | Purchase | 800 | 13.85 | 11,080 | D |
| 08 Aug 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 06 Aug 2024 | Purchase | 2,000 | 13.81 | 27,620 | D |
| 07 Aug 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 05 Aug 2024 | Purchase | 5,500 | 13.18 | 72,490 | D |
| 05 Aug 2024 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 02 Aug 2024 | Purchase | 1,000 | 15.15 | 15,150 | D |
| 24 Jul 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 23 Jul 2024 | Purchase | 1,500 | 15.89 | 23,835 | D |
| 22 Jul 2024 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 18 Jul 2024 | Purchase | 1,000 | 16 | 16,000 | D |
| 17 Jun 2024 06:10 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 13 Jun 2024 | Purchase | 174,825 | 14.3 | 2,499,998 | D |
| 03 Apr 2024 06:10 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 01 Apr 2024 | Purchase | 3,000 | 19.08 | 57,240 | D |
| 26 Mar 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 22 Mar 2024 | Purchase | 2,500 | 19.98 | 49,950 | D |
| 22 Mar 2024 06:02 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 20 Mar 2024 | Purchase | 1,500 | 17.68 | 26,520 | D |
| 07 Mar 2024 09:41 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 05 Mar 2024 | Purchase A | 3,500 | 12.49 | 43,715 | D |
| 07 Mar 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 05 Mar 2024 | Purchase | 30,500 | 12.49 | 380,945 | D |
| 06 Mar 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 04 Mar 2024 | Purchase | 4,100 | 13.03 | 53,423 | D |
| 21 Feb 2024 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 16 Feb 2024 | Purchase | 10,800 | 11.16 | 120,528 | D |
| 20 Feb 2024 06:04 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 15 Feb 2024 | Purchase | 12,700 | 11.07 | 140,589 | D |
| 14 Nov 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 10 Nov 2023 | Purchase | 5,000 | 10.1675 | 50,838 | D |
| 07 Nov 2023 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 03 Nov 2023 | Purchase | 3,500 | 9.11 | 31,885 | D |
| 31 Oct 2023 06:16 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 27 Oct 2023 | Purchase | 500 | 8.57 | 4,285 | D |
| 30 Oct 2023 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 26 Oct 2023 | Purchase | 2,500 | 7.97 | 19,925 | D |
| 27 Oct 2023 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 25 Oct 2023 | Purchase | 2,500 | 7.91 | 19,775 | D |
| 12 Oct 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 10 Oct 2023 | Purchase | 1,000 | 9.07 | 9,070 | D |
| 05 Oct 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 04 Oct 2023 | Purchase | 2,000 | 8.63 | 17,260 | D |
| 28 Sep 2023 06:05 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 26 Sep 2023 | Purchase | 600 | 8.71 | 5,226 | D |
| 21 Sep 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 19 Sep 2023 | Purchase | 4,000 | 8.95 | 35,800 | D |
| 13 Sep 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 11 Sep 2023 | Purchase | 1,000 | 9.48 | 9,480 | D |
| 24 Aug 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 22 Aug 2023 | Purchase | 1,000 | 9.97 | 9,970 | D |
| 08 Aug 2023 06:05 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 04 Aug 2023 | Purchase | 2,000 | 10.55 | 21,100 | D |
| 25 Jul 2023 06:15 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 21 Jul 2023 | Purchase | 1,000 | 9.2 | 9,200 | D |
| 17 Jul 2023 06:15 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 13 Jul 2023 | Purchase | 250 | 9.49 | 2,372 | D |
| 18 May 2023 06:01 | GLSI | Greenwich LifeSciences Inc | PATEL SNEHAL | CEO and CFO, 10% | 17 May 2023 | Purchase | 1,000 | 11.69 | 11,690 | D |
| 02 May 2023 06:06 | GLSI | Greenwich LifeSciences Inc | THOMPSON JAYE | VP Clinical Reg Affairs | 28 Apr 2023 | Purchase | 250 | 11.22 | 2,805 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)